Overview
- 13 inspections across 12 sites are on record.
- 51 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2016-06-03.
At a glance
Inspections
13
Sites
12
Observations
51
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Jajco, Inc. DBA Anchor Drugs Pharmacy | 3 Jun 2016 | Human Drugs | View 483 → |
| Wedgewood Connect, LLC | 6 Mar 2014 | Human Drugs | View 483 → |
| Genentech Inc | 6 Sep 2013 | Human Drugs | On file |
| Allure Labs, LLC | 24 May 2013 | Human Drugs | View 483 → |
| Affymax, Inc. | 20 Mar 2013 | Human Drugs |
Sites inspected
Jajco, Inc. DBA Anchor Drugs PharmacySouth San Francisco, United States1 insp.
Wedgewood Connect, LLCSan Jose, United States1 insp.
Genentech IncVacaville, United States1 insp.
Allure Labs, LLCHayward, United States1 insp.
Affymax, Inc.Cupertino, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jeffrey M Watson3 shared
Anh Lac2 shared
William V Millar2 shared
Lance M De Souza2 shared
Carl Lee2 shared
Stephanie A Slater1 shared
Joshua S Hunt1 shared
Jennifer L Johnson1 shared
Rachel C Harrington1 shared
Robert D Tollefsen1 shared
Full investigator report
Get the verbatim findings behind Henry K Lau's 51 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site